These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38091031)

  • 41. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substance use in individuals at clinical high risk of psychosis.
    Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Heinssen R; Bearden CE; Mathalon D; Addington J
    Psychol Med; 2015 Aug; 45(11):2275-84. PubMed ID: 25727300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The characteristics and clinical outcomes of a pluripotent high-risk group with the potential to develop a diverse range of psychiatric disorders.
    Lee TY; Lee H; Lee J; Lee Y; Rhee SJ; Park DY; Paek MJ; Kim EY; Kim E; Roh S; Jung HY; Kim M; Kim SH; Ahn YM; Ha K; Kwon JS
    J Psychiatr Res; 2024 Jun; 174():237-244. PubMed ID: 38653032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specialised early intervention teams for recent-onset psychosis.
    Puntis S; Minichino A; De Crescenzo F; Cipriani A; Lennox B; Harrison R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013288. PubMed ID: 33135811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suicidality, self-harm and psychotic-like symptoms in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen MO; Cannon TD; Suvisaari J; Therman S
    Early Interv Psychiatry; 2017 Apr; 11(2):113-122. PubMed ID: 25582971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reliability and validity of the Comprehensive Assessment of the At Risk Mental State, Italian version (CAARMS-I).
    Fusar-Poli P; Hobson R; Raduelli M; Balottin U
    Curr Pharm Des; 2012; 18(4):386-91. PubMed ID: 22239569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of suicide and suicidal ideation in psychosis: results from an Italian multi-modal pilot program on early intervention in psychosis.
    Preti A; Meneghelli A; Pisano A; Cocchi A;
    Schizophr Res; 2009 Sep; 113(2-3):145-50. PubMed ID: 19570653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ITAlian partnership for psychosis prevention (ITAPP): Improving the mental health of young people.
    Fusar-Poli P; Minichino A; Brambilla P; Raballo A; Bertolino A; Borgatti R; Mensi M; Ferro A; Galderisi S
    Eur Psychiatry; 2021 Sep; 64(1):e62. PubMed ID: 34544509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Nord J Psychiatry; 2021 Feb; 75(2):97-108. PubMed ID: 32762506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mixed-methods study to evaluate the feasibility and preliminary efficacy of delivering the optimal health program (OHP) for youth at clinical high risk (CHR) for psychosis: A study protocol.
    Husain MO; Hawke LD; Lu Y; Kozloff N; Strudwick G; Kiang M; Wang W; Castle D; Foussias G
    PLoS One; 2024; 19(7):e0306968. PubMed ID: 39024237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Xu L; Wang Y; Cui H; Tang Y; Wang J; Tang X; Zhang B; Wei Y; Zhu Y; Jiang L; Qian Z; Li H; Zhang T; Wang J
    Schizophr Res; 2018 Dec; 202():284-290. PubMed ID: 29929774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of motivational impairment: 12-month follow-up of the randomized-controlled trial on extended early intervention for first-episode psychosis.
    Chang WC; Kwong VW; Chan GH; Jim OT; Lau ES; Hui CL; Chan SK; Lee EH; Chen EY
    Eur Psychiatry; 2017 Mar; 41():37-41. PubMed ID: 28049079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motivational impairment predicts functional remission in first-episode psychosis: 3-Year follow-up of the randomized controlled trial on extended early intervention.
    Chang WC; Kwong VWY; Or Chi Fai P; Lau ESK; Chan GHK; Jim OTT; Hui CLM; Chan SKW; Lee EHM; Chen EYH
    Aust N Z J Psychiatry; 2018 Dec; 52(12):1194-1201. PubMed ID: 29475381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
    Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.
    Modinos G; Allen P; Zugman A; Dima D; Azis M; Samson C; Bonoldi I; Quinn B; Gifford GWG; Smart SE; Antoniades M; Bossong MG; Broome MR; Perez J; Howes OD; Stone JM; Grace AA; McGuire P
    Schizophr Bull; 2020 Apr; 46(3):670-679. PubMed ID: 32227226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applying economic models to estimate local economic benefits of improved coverage of early intervention for psychosis.
    Campion J; Taylor MJ; McDaid D; Park AL; Shiers D
    Early Interv Psychiatry; 2019 Dec; 13(6):1424-1430. PubMed ID: 30740880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.